SHANGHAI DUONING BIOLOGICAL TECHNOLOGY CO LTD

Overview

SHANGHAI DUONING BIOLOGICAL TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 9 active FDA Type II Drug Master Files, covering DN FEED 1 + DN FEED B (POWDER); DN feed 1 DN feed B; DN FEED 3 MEDIUM; INTELLI NUCLEASE; TRANSPRO CD 01; TRANSPRO CD 01 MEDIUM.

API / Drug Master Files

SHANGHAI DUONING BIOLOGICAL TECHNOLOGY CO LTD holds 9 active (9 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DN FEED 3 MEDIUMActive2025-12-09
• TRANSPRO CD 01 PLUSActive2025-10-31
• TRANSPRO CD 01Active2025-03-16
• TRANSPRO CD 01 MEDIUM PIN MILLActive2024-10-21
• TRANSPRO CD 01 MEDIUMActive2024-10-21
• TRANSPRO CD 01 PLUS MEDIUMActive2024-10-21
• DN FEED 1 + DN FEED B (POWDER)Active2023-03-16
• INTELLI NUCLEASEActive2022-12-19
• DN feed 1 DN feed BActive2022-01-25

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHANGHAI DUONING BIOLOGICAL TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.